EVUSHELD 150 mg + 150 mg solution for injection

Licence status
Authorised: 25/03/2022
Active substances
Tixagevimab, Cilgavimab
Dosage Form
Solution for injection
Licence number
EU/1/22/1651/001
Licence holder
AstraZeneca AB

Product documents

Licence information

ATC code
J06B IMMUNOGLOBULINS, J06BD03 tixagevimab and cilgavimab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
25/03/2022